PurCell's New Launch Date!
It brings us great excitement to announce that our new product launch date is January 1, 2024! At that time, we will be making StemPur available for purchase on our website.
For more information on the events leading up to this modified launch date, please read the brief update below.
First, PurCell’s patent was published on July 4th, 2023. This marks a major milestone for the company because the patent insulates our competitive position and advantage in the market. Patent Number US 11,692,167 B2 covers our first four products that we are planning to release: StemPur, FibroPur, MyoPur, and HEKPur.
Second, our production processes have been rigorously refined and improved as we strive towards cGMP compliance. We are working hard to meet the FDA’s current Good Manufacturing Practice (cGMP) requirements as swiftly as possible, due to the level of interest we have received from the contract development and manufacturing organization market.
Thirdly, we have gained a crucial new team member who will serve as our Director of Business Development: Henry Lisoukov. His 25+ years of experience in the life science industry, paired with a bachelors in Biochemistry and an MBA in Global Management, makes him a valuable addition to our team.
Lastly, we are closing our seed funding round on December 15th, 2023. We expect to need no further investment for the foreseeable future.
Needless to say, these last six months have been remarkable. We hope the upcoming months and years will be even more so as we embark on this next chapter in our journey!
The PurCell Bio Team.